Pakafyt 200mg Tablet contains sotagliflozin 200mg, a sodium-glucose cotransporter inhibitor with activity against both SGLT1 and SGLT2. It is used in appropriate adults to help reduce the risk of cardiovascular death, hospitalization for heart failure, and urgent heart failure visits.

Sotagliflozin helps increase glucose excretion through the kidneys and also reduces glucose absorption in the intestine. Its effects on glucose and fluid handling may provide cardiovascular and heart-failure benefits in suitable patients.

Pakafyt should be used only according to a doctor's prescription, particularly because kidney function, hydration status, other diabetes medicines, and cardiovascular conditions may affect treatment decisions.

Uses

• Helps reduce the risk of cardiovascular death in appropriate adults
• Helps reduce hospitalization due to heart failure
• Helps reduce urgent heart failure visits
• Used in adults with heart failure
• May be used in adults with type 2 diabetes, chronic kidney disease, and cardiovascular risk factors
• Helps increase urinary elimination of glucose

Benefits

• Helps reduce the risk of certain cardiovascular complications
• Supports heart-failure management in appropriate patients
• Helps promote urinary glucose excretion
• Provides oral cardiometabolic treatment
• May provide additional benefits in patients with type 2 diabetes and chronic kidney disease when appropriately prescribed
• Convenient tablet formulation

Dosage

• Take Pakafyt 200mg exactly as prescribed by your doctor.
• The approved sotagliflozin starting dose is 200mg once daily, taken no more than one hour before the first meal of the day.
• Your doctor may increase the dose to 400mg once daily after evaluating your response and tolerability.
• Swallow the tablet whole with water. Do not cut, crush, or chew it.
• Your doctor may assess kidney function and hydration status before and during treatment.
• Do not change the dose or stop treatment without medical advice.

Possible Side Effects

Some people may experience:

• Diarrhea
• Urinary tract infections
• Genital fungal infections
• Increased urination
• Dehydration
• Dizziness or low blood pressure
• Nausea
• Low blood sugar, particularly when combined with insulin or insulin-secretagogue medicines

Rare but serious complications include diabetic ketoacidosis, severe dehydration, serious urinary infections, and Fournier's gangrene. Seek urgent medical attention for severe weakness, persistent vomiting, abdominal pain, difficulty breathing, confusion, or severe pain/swelling in the genital or perineal area.

Precautions

• Tell your doctor if you have kidney disease, diabetes, heart failure, low blood pressure, dehydration, or a history of diabetic ketoacidosis.
• Maintain adequate fluid intake unless your doctor has advised fluid restriction.
• Sotagliflozin can increase the risk of dehydration and low blood pressure.
• The risk of hypoglycemia may increase when used with insulin or certain medicines that stimulate insulin release.
• Tell your doctor before major surgery or prolonged fasting; sotagliflozin may need to be temporarily stopped.
• Inform your doctor about all medicines, vitamins, and supplements you take.
• Sotagliflozin is not appropriate for self-treatment of type 1 diabetes because of the risk of ketoacidosis.
• Discuss use during pregnancy or breastfeeding with your healthcare professional.

FAQs

Q1: What is Pakafyt 200mg Tablet used for?

Pakafyt 200mg contains sotagliflozin and is used in appropriate adults to reduce the risk of cardiovascular death, hospitalization for heart failure, and urgent heart failure visits.

Q2: How does Pakafyt 200mg work?

Sotagliflozin inhibits SGLT1 and SGLT2, helping reduce glucose absorption in the intestine and increase glucose excretion through the kidneys.

Q3: How should Pakafyt 200mg be taken?

The approved sotagliflozin regimen starts at 200mg once daily, taken no more than one hour before the first meal of the day. Follow your doctor's specific instructions.

Q4: Can Pakafyt cause dehydration?

Yes. Sotagliflozin can increase fluid loss through urine and may cause dehydration, dizziness, or low blood pressure. Maintain appropriate fluid intake as advised by your doctor.

Q5: Can Pakafyt cause low blood sugar?

It can increase the risk of hypoglycemia when used with insulin or insulin-secretagogue medicines. Your doctor may adjust the dose of those medicines if necessary.

Q6: Can Pakafyt be used before surgery?

Sotagliflozin should generally be withheld for at least 3 days, if possible, before major surgery or procedures involving prolonged fasting. Restart it when clinically stable and eating normally, as directed by your doctor.